Financial Architects, Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$4.87 - $7.08 $974 - $1,416	-200 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.6 - $7.8 $3,960 - $4,680	-600 Reduced 75.0%	200 $1,000
Q1 2019 May 13, 2019	BUY	$5.76 - $8.95 $3,456 - $5,370	600 Added 300.0%	800 $6,000
Q1 2019 May 03, 2019	BUY	$5.76 - $8.95 $1,152 - $1,789	200 New	200 $1,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.05B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.